
“Attention Investors: Important Notification from Levi and Korsinsky Regarding Neumora Therapeutics Inc. (Ticker: 986029)”
Suffered a Loss on Neumora Therapeutics, Inc. Investment? Seeking Potential Recovery Under Federal Securities Laws NEW YORK, NY / ACCESS Newswire / February 15, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below…